Detection of growth hormone abuse in sport

被引:109
作者
Powrie, J. K.
Bassett, E. E.
Rosen, T.
Jorgensen, J. O.
Napoli, R.
Sacca, L.
Christiansen, J. S.
Bengtsson, B. A.
Soenksen, P. H.
机构
[1] Guys Hosp, Guys & St Thomas NHS Fdn Trust, Dept Endocrinol & Diabet, London SE1 9RT, England
[2] Univ Kent, Math Inst, Canterbury CT2 7NF, Kent, England
[3] Univ Naples Federico II, Dept Internal Med & Cardiovasc Sci, I-80131 Naples, Italy
[4] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
[5] Sahlgrens Univ Hosp, Dept Endocrinol, SE-41345 Gothenburg, Sweden
关键词
growth hormone; doping in sport; insulin-like growth factor I; procollagen type III;
D O I
10.1016/j.ghir.2007.01.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: To develop a test for GH abuse in sport. Design: A double blind placebo controlled study of one month's GH administration to 102 healthy non-competing but trained subjects. Blood levels of nine markers of GH action were measured throughout the study and for 56 days after cessation of GH administration. Blood samples were also taken from 813 elite athletes both in and out of competition. Results: GH caused a significant change in the nine measured blood markers. Men were more sensitive to the effects of GH than women. IGF-I and N-terminal extension peptide of procollagen type III were selected to construct formulae which gave optimal discrimination between the GH and placebo groups. Adjustments were made to account for the fall in IGF-I and P-III-P with age and the altered distribution seen in elite athletes. Using a cut-off specificity of 1: 10,000 these formulae would allow the detection of up to 86% of men and 60% of women abusing GH at the doses used in this study. Conclusions: We report a methodology that will allow the detection of GH abuse. This will provide the basis of a robust and enforceable test identifying those who are already cheating and provide a deterrent to those who may be tempted to do so. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:220 / 226
页数:7
相关论文
共 20 条
[1]   Isotopic differences in human growth hormone preparations [J].
Abramson, FP ;
Osborn, BL ;
Teffera, Y .
ANALYTICAL CHEMISTRY, 1996, 68 (11) :1971-1972
[2]   GROWTH-HORMONE HETEROGENEITY - GENES, ISOHORMONES, VARIANTS, AND BINDING-PROTEINS [J].
BAUMANN, G .
ENDOCRINE REVIEWS, 1991, 12 (04) :424-449
[3]   Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women [J].
Burman, P ;
Johansson, AG ;
Siegbahn, A ;
Vessby, B ;
Karlsson, FA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :550-555
[4]   GROWTH-HORMONE TREATMENT IN GROWTH HORMONE-DEFICIENT ADULTS .2. EFFECTS ON EXERCISE PERFORMANCE [J].
CUNEO, RC ;
SALOMON, F ;
WILES, CM ;
HESP, R ;
SONKSEN, PH .
JOURNAL OF APPLIED PHYSIOLOGY, 1991, 70 (02) :695-700
[5]   GROWTH-HORMONE TREATMENT IN GROWTH HORMONE-DEFICIENT ADULTS .1. EFFECTS ON MUSCLE MASS AND STRENGTH [J].
CUNEO, RC ;
SALOMON, F ;
WILES, CM ;
HESP, R ;
SONKSEN, PH .
JOURNAL OF APPLIED PHYSIOLOGY, 1991, 70 (02) :688-694
[6]   The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men [J].
Dall, R ;
Longobardi, S ;
Ehrnborg, C ;
Keay, N ;
Rosén, T ;
Jorgensen, JOL ;
Cuneo, RC ;
Boroujerdi, MA ;
Cittadini, A ;
Napoli, R ;
Christiansen, JS ;
Bengtsson, BA ;
Sacca, L ;
Baxter, RC ;
Basset, EE ;
Sönksen, PH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4193-4200
[7]   Toward the development of a test for growth hormone (GH) abuse:: A study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting [J].
Healy, ML ;
Dall, R ;
Gibney, J ;
Bassett, E ;
Ehrnborg, C ;
Pentecost, C ;
Rosen, T ;
Cittadini, A ;
Baxter, RC ;
Sönksen, PH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) :641-649
[8]   Cancer in acromegaly [J].
Jenkins, P .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1998, 9 (09) :360-366
[9]  
JORGENSEN JOL, 1989, LANCET, V1, P1221
[10]   Serum IGF-I and IGF binding proteins 2 and 3 as potential markers of doping with human GH [J].
Kicman, AT ;
Miell, JP ;
Teale, JD ;
Powrie, J ;
Wood, PJ ;
Laidler, P ;
Milligan, PJ ;
Cowan, DA .
CLINICAL ENDOCRINOLOGY, 1997, 47 (01) :43-50